PSIX vs DCGO vs GNRC vs OPRX vs HUBB

For growth investors, DocGo Inc.

(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus -100. 0% for Power Solutions International, Inc. (PSIX). Power Solutions International, Inc. (PSIX) offers the better valuation at 14. 6x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate Power Solutions International, Inc. (PSIX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Power Solutions International, Inc.

(PSIX) is the cheapest at 14. 6x versus Generac Holdings Inc. at 99. 2x. On forward P/E, OptimizeRx Corporation is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Power Solutions International, Inc.

(PSIX) delivered a total return of +1080%, compared to -93. 6% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: GNRC returned +666. 1% versus DCGO's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Hubbell Incorporated (HUBB) is the lower-risk stock at 1.

38β versus Power Solutions International, Inc. 's 3. 33β — meaning PSIX is approximately 142% more volatile than HUBB relative to the S&P 500. On balance sheet safety, OptimizeRx Corporation (OPRX) carries a lower debt/equity ratio of 4% versus 85% for Power Solutions International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), DocGo Inc.

(DCGO) is pulling ahead at 522574% versus -100. 0% for Power Solutions International, Inc. (PSIX). On earnings-per-share growth, the picture is similar: OptimizeRx Corporation grew EPS 124. 5% year-over-year, compared to -1122. 2% for DocGo Inc.. Over a 3-year CAGR, DCGO leads at 89. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Power Solutions International, Inc.

(PSIX) is the more profitable company, earning 21. 5% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 21. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HUBB leads at 20. 8% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — OPRX leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 7.

0x forward P/E versus 30. 9x for Generac Holdings Inc. — 23. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 156. 4% to $17. 00.

In this comparison, HUBB (1.

1% yield) pays a dividend. PSIX, DCGO, GNRC, OPRX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Hubbell Incorporated (HUBB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.

1% yield, +410. 7% 10Y return). DocGo Inc. (DCGO) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HUBB: +410. 7%, DCGO: -93. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PSIX (Industrials) and DCGO (Healthcare) and GNRC (Industrials) and OPRX (Healthcare) and HUBB (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PSIX is a small-cap deep-value stock; DCGO is a small-cap high-growth stock; GNRC is a mid-cap quality compounder stock; OPRX is a small-cap high-growth stock; HUBB is a mid-cap quality compounder stock. HUBB pays a dividend while PSIX, DCGO, GNRC, OPRX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.